脑部放疗，上午比下午敏感许多！0 @. y5 E; K5 f2 `" R m; C
% T/ X$ F0 w; G" C# ~6 D
/ Z# k! \4 Q+ |Cancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.
' `8 z* r: }+ I' ]6 {3 jGamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?
8 X2 n8 w5 j: Y% w3 xRahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.5 h- S/ V+ x* o# B% d
SourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.# t$ m# L: h. F* z7 F5 t
, @5 N3 @4 D. o8 v0 G AAbstract
& x# s" Q8 l* xBACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.1 Z' n, `* V& b9 M5 m5 W0 ]
2 {, P+ l; b! C& V
METHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic., y8 S# {3 P; I8 q
$ Z% d. {: \9 O6 u9 B3 u5 C
RESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026).
4 i& X0 @6 [6 F7 W0 h3 f* i( I! T8 S9 @- s$ T
CONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series., V9 y; l# E" s( _* t
5 Y: m4 p4 ]! `; q |
1 p( q& D4 W% n7 @* g; a
显身卡
